Literature DB >> 22199301

Impact of cyclooxygenase-2 in breast cancer.

Friederike Hoellen1, Katharina Kelling, Christine Dittmer, Klaus Diedrich, Michael Friedrich, Marc Thill.   

Abstract

Prostaglandin metabolism plays a pivotal role in inflammatory processes and has also been demonstrated to have a role in carcinogenesis, tumor differentiation and tumor growth in breast cancer. Cyclooxygenase-2 (COX-2) is the key involved enzyme, as it triggers prostaglandin synthesis. We reviewed the current literature regarding the impact of prostaglandin metabolism on breast cancer and illustrated the current evidence of the COX-2 influence on breast cancer, delineating possible future prophylactic and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22199301

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  22 in total

Review 1.  Long non-coding RNA: a versatile regulator of the nuclear factor-κB signalling circuit.

Authors:  Xiaohua Mao; Zhenyi Su; Adnan K Mookhtiar
Journal:  Immunology       Date:  2017-01-19       Impact factor: 7.397

2.  MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.

Authors:  Xiao-Li Wu; Bin Cheng; Pei-Yuan Li; Huan-Jun Huang; Qiu Zhao; Zi-Li Dan; De-An Tian; Peng Zhang
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

Review 3.  Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.

Authors:  Subash C Gupta; Nikee Awasthee; Vipin Rai; Srinivas Chava; Venugopal Gunda; Kishore B Challagundla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-19       Impact factor: 10.680

4.  Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma-A Histopathological Study.

Authors:  Miguel A Ortega; Oscar Fraile-Martinez; Cielo García-Montero; Sandra Borja-Vergel; Diego Torres-Carranza; Leonel Pekarek; Coral Bravo Arribas; Juan A De León-Luis; Cristina Sánchez-Rojo; Miguel Angel Alvarez-Mon; Natalio García-Honduvilla; Julia Buján; Santiago Coca; Melchor Alvarez-Mon; Miguel A Saez; Luis G Guijarro
Journal:  Medicina (Kaunas)       Date:  2022-05-28       Impact factor: 2.948

5.  Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients.

Authors:  Kailash Mosalpuria; Carolyn Hall; Savitri Krishnamurthy; Ashutosh Lodhi; D Michael Hallman; Mary S Baraniuk; Anirban Bhattacharyya; Anthony Lucci
Journal:  Mol Clin Oncol       Date:  2014-06-23

6.  Baicalein inhibits DMBA/TPA-induced skin tumorigenesis in mice by modulating proliferation, apoptosis, and inflammation.

Authors:  Guo-Zhang Ma; Chun-Hui Liu; Bin Wei; Jie Qiao; Tao Lu; Hua-Chen Wei; Hong-Duo Chen; Chun-Di He
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

7.  Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression.

Authors:  Anthony J Apostoli; Jennifer M Roche; Mark M Schneider; Sandip K SenGupta; Michael A Di Lena; Rachel E Rubino; Nichole T Peterson; Christopher J B Nicol
Journal:  Mol Cancer       Date:  2015-04-15       Impact factor: 27.401

8.  Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.

Authors:  Colleen A Fordyce; Kelley T Patten; Tim B Fessenden; RosaAnna DeFilippis; E Shelley Hwang; Jianxin Zhao; Thea D Tlsty
Journal:  Breast Cancer Res       Date:  2012-12-07       Impact factor: 6.466

9.  Remarkable Anticancer Activity of Teucrium polium on Hepatocellular Carcinogenic Rats.

Authors:  Ariyo Movahedi; Rusliza Basir; Asmah Rahmat; Mohammad Charaffedine; Fauziah Othman
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-13       Impact factor: 2.629

10.  Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.

Authors:  D M Fraser; F M Sullivan; A M Thompson; C McCowan
Journal:  Br J Cancer       Date:  2014-06-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.